exalenz bioscience ltd
(EXEN:Tel Aviv Stock Exchange)
Chief Executive Officer, Exalenz Bioscience Ltd
|Age||Total Calculated Compensation||This person is connected to 15 board members in 1 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Lawrence Cohen has been Chief Executive Officer of Exalenz Bioscience Ltd. since March 4, 2013. Previously, Mr. Cohen served as Chief Executive Officer of SenGenix, Inc. He served also as Director at SenGenix, Inc. Mr. Cohen served as the President of International Technidyne Corp. (ITC), a subsidiary of Thoratec Corporation from May 2001 to November 4, 2010. Prior to joining ITC in May 2001, Mr. Cohen served as Chief Executive Officer of HemoSense, Inc. from August ...
4 Ha’maayan St.Phone: 972 8 973 7500
Modiin, -- 71700
Fax: 972 8 973 7501
Board Members Memberships*There is no Board Members Memberships data available.
University of Toronto
|There is no Competitor Compensation data available.|